Gland Pharma Ltd Half Yearly Results

Gross Sales

2,808.96

2,807.54

3,082.61

2,582.12

1,723.3

Excise Duty

0

0

0

0

0

Net Sales

2,808.96

2,807.54

3,082.61

2,582.12

1,723.3

Other Operating Income

0

0

0

0

0

Other Income

102.52

111.09

79.54

90.7

100.45

Total Income

2,911.48

2,918.63

3,162.14

2,672.81

1,823.75

Total Expenditure

2,101.49

2,246.09

2,367.57

1,964.08

1,321.77

PBIDT

809.99

672.54

794.58

708.73

501.98

Interest

30.27

11.73

15.24

10.96

4.82

PBDT

779.72

660.81

779.34

697.77

497.15

Depreciation

192.09

185.79

197.95

146.62

75.15

Minority Interest Before NP

0

0

0

0

0

Tax

198.28

173.7

197.61

148.13

120.25

Deferred Tax

-1.88

-5.97

-0.5

14.84

-8.88

Reported Profit After Tax

391.23

307.29

384.28

388.18

310.63

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

391.23

307.29

384.28

388.18

310.63

Extra-ordinary Items

0

0

0

0

-56.46

Adjusted Profit After Extra-ordinary item

391.23

307.29

384.28

388.18

367.09

EPS (Unit Curr.)

23.75

18.65

23.33

23.57

18.86

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

16.48

16.48

16.47

16.47

16.47

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

28.83

23.95

25.77

27.44

29.12

PBDTM(%)

-

-

-

-

-

PATM(%)

13.92

10.94

12.46

15.03

18.02